Stocks · Healthcare · Medical - Care Facilities
Viemed Healthcare, Inc. VMD
$9.13 +0.55% Close, Oct 2, 2026 · NASDAQ · Market cap $347.7M
Strong growthHigh qualityInexpensive vs sectorLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $301.6M, up 25.2% from a year earlier, accelerating from 23.1% a quarter earlier.
- Diluted EPS over the last four quarters was $0.36, up 9.6% year over year.
- The stock is 26% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 28%
- EPS growth (TTM, YoY)Top 49%
- Revenue growth, 3-year CAGRTop 26%
- Revenue growth accelerationTop 28%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 13%
- Gross marginBottom 42%
- Operating marginTop 30%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 11%
- Net debt / EBITDA (lower is better)Top 36%
- Interest coverTop 9%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 14%
- Free-cash-flow yieldTop 10%
- EBITDA / enterprise valueTop 5%
- Sales / enterprise valueTop 12%
- P/E vs own 5-year history (lower is better)Top 43%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 44%
- 6-month returnBottom 37%
- 1-year return vs S&P 500Top 35%
- Distance from 52-week highTop 43%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 24%
- Consecutive EPS beatsBottom 20%
- Upside to consensus price targetBottom 45%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 28%
- Maximum drawdown, 3 yearsTop 14%
- Beta vs S&P 500 (lower is better)Top 17%
- Net debt / EBITDA (lower is better)Top 36%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 23.1% | 25.2% | ↑ |
| EPS growth (YoY) | 27.2% | 9.6% | ↓ |
| Gross margin | 58.2% | 57.2% | ↓ |
| Operating margin | 8.5% | 8.1% | ↓ |
| FCF margin | -1.5% | 9.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 25.2% | 23.1% | ↑ | Top 28% |
| EPS growth (TTM, YoY) | 9.6% | 27.2% | ↓ | Top 49% |
| Gross margin | 57.2% | 58.2% | ↓ | Bottom 42% |
| Operating margin | 8.1% | 8.5% | ↓ | Top 30% |
| Net margin | 4.8% | 5.8% | ↓ | — |
| Free-cash-flow margin | 9.7% | -1.5% | ↑ | — |
| Return on invested capital | 11.0% | — | Top 13% | |
| Revenue growth, 3-year CAGR | 24.9% | — | Top 26% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -22.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -3.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.02×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 17.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 4.99%
- Shareholder yield
- 4.99%
- Share count change, 1 year
- +0.1%
- Share count change, 3-year CAGR
- +0.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -14.6%
- Average 2-day reaction, last 8
- +0.6%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $14.00
- Target vs current price
- +53.3%
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | -41.7% | +0.2% | -16.6% | -24.4% | — |
| May 5, 2026 | -33.3% | +2.3% | -4.7% | +0.0% | +24.1% |
| Mar 4, 2026 | +16.7% | +1.5% | +6.1% | +2.9% | +11.8% |
| Nov 5, 2025 | +0.0% | -1.7% | -2.9% | +3.4% | +22.3% |
| Aug 6, 2025 | -5.9% | +2.1% | +17.7% | +7.6% | +3.5% |
| May 7, 2025 | +0.0% | -1.8% | -6.9% | -7.2% | -19.9% |
| Mar 10, 2025 | -9.1% | -1.3% | +0.9% | -8.3% | -9.5% |
| Nov 6, 2024 | +25.0% | +3.9% | +6.8% | -0.9% | -7.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | $0.07 | $0.12 | -41.7% | $78.1M |
| May 5, 2026 | $0.06 | $0.09 | -33.3% | $75.4M |
| Mar 4, 2026 | $0.14 | $0.12 | +16.7% | $76.2M |
| Nov 5, 2025 | $0.09 | $0.09 | +0.0% | $71.9M |
| Aug 6, 2025 | $0.08 | $0.09 | -5.9% | $63.1M |
| May 7, 2025 | $0.06 | $0.06 | +0.0% | $59.1M |
| Mar 10, 2025 | $0.10 | $0.11 | -9.1% | $60.7M |
| Nov 6, 2024 | $0.10 | $0.08 | +25.0% | $58.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 25.1× | 27.3× | 38th | Top 14% |
| P/E (forward) | 22.1× | — | — | — |
| EV / EBITDA | 6.5× | — | — | Top 5% |
| EV / Sales | 1.16× | — | — | Top 12% |
| Free-cash-flow yield | 8.41% | — | — | Top 10% |
| Earnings yield | 3.98% | — | — | Top 14% |
P/E over the past five years
Range 16.3× – 73.7× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +31.7%
- Earnings per share growth (TTM)
- +9.6%
- Change in P/E multiple
- +65.4%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -11.3%
- 200-day average slope (20 days)
- +2.3%
- Distance from 50-day average
- -3.2%
- Distance from 200-day average
- -2.2%
- RSI (14)
- 51.2
- Relative volume
- 1.48×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 44.3%
- Volatility vs own 5-year history
- 67th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.51
- Correlation with S&P 500
- 0.22
- Current drawdown from 1-year high
- -26.0%
- Maximum drawdown, 3 years
- -40.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 19, 2021 | Mar 7, 2022 | -66.8% | 263 days | 281 days (Apr 19, 2023) |
| Apr 21, 2023 | Aug 1, 2025 | -49.6% | 571 days | 230 days (Jul 2, 2026) |
| Jul 13, 2026 | Aug 20, 2026 | -30.5% | 28 days | Not yet recovered |
| Oct 20, 2020 | Dec 31, 2020 | -22.9% | 50 days | 24 days (Feb 5, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $347.7M
- P/E (TTM)
- 25.1
- EPS, diluted (TTM)
- $0.36
- Revenue (TTM)
- $301.6M
- 52-week range
- $6.05 – $12.61
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $117.1M | $138.8M | $183.0M | $224.3M | $270.3M |
| Gross profit | $73.4M | $84.7M | $112.8M | $133.2M | $155.5M |
| Operating income | $11.6M | $8.3M | $14.3M | $17.9M | $20.7M |
| Net income | $9.1M | $6.2M | $10.2M | $11.3M | $14.9M |
| EPS (diluted) | $0.22 | $0.15 | $0.25 | $0.28 | $0.37 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $58.0M | $60.7M | $59.1M | $63.1M | $71.9M | $76.2M | $75.4M | $78.1M |
| Net income | $3.9M | $4.3M | $2.6M | $3.2M | $3.5M | $5.6M | $2.6M | $2.8M |
| EPS (diluted) | $0.10 | $0.10 | $0.06 | $0.08 | $0.09 | $0.14 | $0.06 | $0.07 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $22.5M | $27.7M | $45.2M | $39.1M | $51.9M |
| Capital expenditure | -$19.7M | -$22.9M | -$26.1M | -$37.8M | -$40.0M |
| Free cash flow | $2.8M | $4.8M | $19.1M | $1.3M | $11.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$1.4M | -$9.7M | -$594,000 | -$1.1M | -$11.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $10.7M
- Total assets
- $204.2M
- Total liabilities
- $58.3M
- Total debt
- $11.6M
- Net debt
- $920,000
- Shareholders’ equity
- $144.0M
As of Jun 30, 2026 (filed Aug 3, 2026).
Short interest
- Shares sold short
- 1,323,822
- Days to cover
- 5.24
- Change vs previous report
- +9.7%
FINRA short interest, settlement date Sep 15, 2026.